Treating acute gouty arthritis with selective COX 2 inhibitors
- 2 November 2002
- Vol. 325 (7371), 980-981
- https://doi.org/10.1136/bmj.325.7371.980
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritisBMJ, 2002
- Therapeutic potential of COX-2 inhibitors in arthritisExpert Opinion on Investigational Drugs, 2001
- Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.2001
- Nomenclature for COX-2 InhibitorsThe Lancet, 2000
- Do Cyclooxygenase-2 Inhibitors Provide Benefits Similar to Those of Traditional Nonsteroidal Anti-Inflammatory Drugs, with Less Gastrointestinal Toxicity?Annals of Internal Medicine, 2000
- Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes.1998
- Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.Proceedings of the National Academy of Sciences, 1994